Efficacy of antiviral therapy and host-virus interactions visualised using serial liver sampling with fine-needle aspirates
Novel therapies for chronic hepatitis B (CHB), such as RNA interference, target all viral RNAs for degradation, whereas nucleoside analogues are thought to block reverse transcription with minimal impact on viral transcripts. However, limitations in technology and sampling frequency have been obstac...
Saved in:
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
September 2023
|
| In: |
JHEP reports
Year: 2023, Volume: 5, Issue: 9, Pages: 1-10 |
| ISSN: | 2589-5559 |
| DOI: | 10.1016/j.jhepr.2023.100817 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.jhepr.2023.100817 Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S2589555923001489 |
| Author Notes: | Samuel C. Kim, Jeffrey J. Wallin, Yanal Ghosheh, Muhammad Atif Zahoor, Juan Diego Sanchez Vasquez, Shirin Nkongolo, Scott Fung, Patricia Mendez, Jordan J. Feld, Harry L.A. Janssen, Adam J. Gehring |
| Summary: | Novel therapies for chronic hepatitis B (CHB), such as RNA interference, target all viral RNAs for degradation, whereas nucleoside analogues are thought to block reverse transcription with minimal impact on viral transcripts. However, limitations in technology and sampling frequency have been obstacles to measuring actual changes in HBV transcription in the liver of patients starting therapy. |
|---|---|
| Item Description: | Online veröffentlicht am 19. Juni 2023, Artikelversion vom 4. August 2023 Gesehen am 07.12.2023 |
| Physical Description: | Online Resource |
| ISSN: | 2589-5559 |
| DOI: | 10.1016/j.jhepr.2023.100817 |